You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 12, December 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Uveal Melanoma in Children and Adolescents

Charles C. Barr, MD; LTC Ian W. McLean, MC, USA; Lorenz E. Zimmerman, MD

Arch Ophthalmol. 1981;99(12):2133-2136.


Abstract

• Five-year survival data were available in 78 cases originally classified as uveal melanomas in patients less than 20 years old. Forty-two were malignant melanomas arising from the choroid and/or ciliary body; 13 patients from this group died of metastatic disease. Factors that significantly correlated with fatality were a red, painful eye, extraocular extension at enucleation, basal tumor diameter greater than 10 mm, increased mitotic activity, and tumor necrosis. There were 36 iridic tumors; nine were reclassified as nevi. Of the 27 patients with iridic melanomas, only four died of metastases. The predominant factors relating to fatal outcome were glaucoma, extension of tumor into the ciliary body, diffuse growth, deep angle invasion, scleral invasion by tumor cells, and increased mitotic activity. Except for their relative rarity, uveal melanomas in children and adolescents did not differ significantly from their counterparts in adults.



Author Affiliations

From the Registry of Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC (Drs McLean and Zimmerman), and the Bascom Palmer Eye Institute, University of Miami School of Medicine (Dr Barr).


Footnotes

Accepted for publication Feb 3, 1981.

The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

Reprint requests to Department of Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 (Dr McLean).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tumor Basal Area and Metastatic Death After Proton Beam Irradiation for Choroidal Melanoma
Li et al.
Arch Ophthalmol 2003;121:68-72.
ABSTRACT | FULL TEXT  

Iris Melanoma in a 6-Year-Old Girl
Pe'er
Arch Ophthalmol 2001;119:780-781.
FULL TEXT  

Leucocoria as the presenting sign of a ciliary body melanoma in a child
DEMIRCI et al.
Br J Ophthalmol 2001;85:110f-110.
FULL TEXT  

Metastatic Melanoma Death Rates by Anatomic Site After Proton Beam Irradiation for Uveal Melanoma
Li et al.
Arch Ophthalmol 2000;118:1066-1070.
ABSTRACT | FULL TEXT  

Uveal Melanoma in Young Patients
Singh et al.
Arch Ophthalmol 2000;118:918-923.
ABSTRACT | FULL TEXT  

Ring melanoma---a rare cause of refractory glaucoma
Lee et al.
Br J Ophthalmol 1999;83:194-198.
ABSTRACT | FULL TEXT  

Evaluation of Imaging Techniques for Detection of Extraocular Extension of Choroidal Melanoma
Scott et al.
Arch Ophthalmol 1998;116:897-899.
ABSTRACT | FULL TEXT  

The Persisting Pseudomelanoma Problem
Chang et al.
Arch Ophthalmol 1984;102:726-727.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.